Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer

Mediators of Inflammation

Volumn 13, Issue 5-6, 2004, Pages 369-372

  Aydemir, Selim ^a   Tekin, Isak Ozel ^a   Numanoglu, Gamze ^a   Borazan, Ali ^a   Ustundag, Yucel ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Eosinophil; Eosinophil cationic protein; Gastric juice; Gastric ulcer; Helicobacter pylori; Serum

Indexed keywords

PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; EOSINOPHIL; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; INTERMETHOD COMPARISON; MALE; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY; STOMACH JUICE; STOMACH ULCER;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILIA; EOSINOPHILS; FEMALE; GASTRIC JUICE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; STOMACH ULCER;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 10944244216     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350400014115     Document Type: Article

References (34)

1. Bertram TA, Murray PD, Morgan DR, Jerdak G, Yang P, Czinn S. Gastritis associated with infection by Helicobacter pylori in humans: geographical differences. Scand J Gastroenterol Suppl 1991; 181: 1-8.
2. Wyle FA. Helicobacter pylori: current perspectives. J Clin Gastroenterol 1991; 13 (Suppl 1): 114-124.
3. Tytgat GN, Noach L, Rauws EA. Helicobacter pylori. Scand J Gastroenterol Suppl 1991; 187: 1-8.
4. Takenaka R, Yokota K, Mizuno M, et al. Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori. Helicobacter 2004; 9: 194-200.
5. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997; 349: 1020-1022.
6. Crabtree JE. Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig Dis Sci 1998; 43: 46-55.
7. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998; 54: 139-150.
8. Bayraktaroglu T, Aras AS, Aydemir S, et al. Serum levels of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis. Mediators Inflamm 2004; 13: 25-28.
9. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991; 324: 1110-1118.
10. Saitoh O, Kojima K, Sugi K, et al. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am J Gastroenterol 1999; 94: 3513-3520.
11. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592-1600.
12. Levy AM, Kita K. The eosinophil in gut inflammation: effector or director? Gastroenterology 1996; 110: 952-954.
13. Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol 1999; 94: 3521-3529.
14. Winterkamp S, Raithel M, Hahn EG. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. J Clin Gastroenterol 2000; 30: 170-175.
15. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology 1992; 103: 137-145.
16. Miyasato M, Tsuda S, Nakama T, et al. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis. J Dermatol 1996; 23: 382-388.
17. Venge P, Bystrom J. Eosinophil cationic protein (ECP). Int J Biochem Cell Biol 1998; 30: 433-437.
18. Peterson CG, Eklund E, Taha Y, Raab Y, Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 2002; 97: 1755-1762.
19. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999; 51: 213-340.
20. Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328: 257-265.
21. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci 1991; 36: 435-440.
22. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-199.
23. Frommer DJ, Carrick J, Lee A, Hazell SL. Acute presentation of Campylobacter pylori gastritis. Am J Gastroenterol 1988; 83: 1168-1171.
24. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9 (Suppl 2): 33-39.
25. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29: 559-578.
26. Niemela S, Karttunen T, Kerola T. Chronic gastritis in patients with gastric ulcer; a 10-year follow-up. Scand J Gastroenterol 1995; 30: 428-433.
27. Yang HB, Sheu BS, Su IJ, Chien CH, Lin XZ. Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci 1997; 42: 1835-1840.
28. Fiocca R, Luinetti O, Villani L, Chiaravalli AM, Capella C, Solcia B. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol Suppl 1994; 205: 11-21.
29. Whitney AE, Guarner J, Hutwagner L, Gold BD. Helicobacter pylori gastritis in children and adults: comparative histopathologic study. Ann Diagn Pathol 2000; 4: 279-285.
30. Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996; 10 (Suppl 1): 29-37.
31. Hallgren R, Colombel JF, Dahl R, et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med 1989; 86: 56-64.
32. Raab Y, Fredens K, Gerdin B, Hallgren R. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci 1998; 43: 1061-1070.
33. Berstad K, Berstad A, Jr, Sjodahl R, Weberg R, Berstad A. Eosinophil cationic protein and phospholipase A2 activity in human gastric juice, With emphasis on Helicobacter pylori status and effects of antacids. Scand J Gastroenterol 1992; 27: 1011-1017.
34. Ojetti V, Armuzzi A, De Luca A, et al. Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria. Int Arch Allergy Immunol 2001; 125: 66-72.